Pubmed | Biomarker | Character | Taxonomy | Relation | Odds (95% CI) |
P-value | Description |
---|---|---|---|---|---|---|---|
34109467 | HE4 | serum HE4 levels | FIGO | tumor size | p<0.001 | Serum HE4 levels was significantly associated with large tumor size | |
27039795 | HE4 | serum HE4 levels | FIGO | tumor size | p<0.001 | Serum HE4 levels were significantly elevated in EC patients with primary tumor diameter >2 cm | |
26260911 | Metabolic syndrome | Metabolic syndrome | FIGO | tumor size | p=0.035 | MS was closely related to tumor size | |
22008707 | ADCmin | ADCmin | FIGO | tumor size | p<0.001 | There were significant correlations between the ADCmin of the primary tumor and tumor maximum size | |
21764107 | SUVmax | the SUVmax of the primary tumor | FIGO | tumor size | p<0.001 | There were significant correlations between the SUVmax of the primary tumor and tumor maximum size | |
18349274 | Prostate-specific membrane antigen | PSMA methylation | FIGO | tumor size | p=0.025 | There was an association between PSMA methylation and tumor size | |
17130035 | oestrogen receptor | oestrogen receptor expression | FIGO | tumor size | p<0.001 | Oestrogen receptor expression and proliferation indices were found to be statistically associated with tumour size | |
32769331 | TROP2 | overexpression | FIGO | tumor size | p≤0.05 | High overexpression of TROP2 was seen in larger size | |
32769331 | TROP2 | overexpression | FIGO | tumor size | High overexpression of TROP2 was seen in larger size | ||
30645608 | GDF-15 | high plasma level of GDF-15 | FIGO | tumor size | p=0.008 | Patients with high plasma level of GDF-15 had significantly larger tumor volume | |
29848072 | miR-29b | miR-29b expression in the peripheral blood | FIGO | tumor size | p<0.05 | miR-29b expression in the peripheral blood was correlated with tumor size | |
29516012 | visfatin | significantly higher concentrations of visfatin | FIGO | tumor size | p=0.003 | The higher mean serum concentration of visfatin has been found in the case of larger tumor size. | |
29516012 | visfatin | Visfatin | FIGO | tumor size | p=0.003 | Significantly higher concentrations of visfatin have been observed in patients with the size of the tumor | |
29114696 | cancer antigen 15-3 | serum cancer antigen 15-3 levels | FIGO | tumor size | p<0.05 | Serum cancer antigen 15-3 levels were also significantly correlated with tumor size | |
27039795 | HE4 | preoperative serum HE4 | FIGO | tumor size | r=0.65 | p<0.001 | Preoperative serum HE4 levels were strongly correlated with primary tumor diameter. |